Autolus Therapeutics Plc (AUTL)

1.585 -0.02 (-0.94%) USD  |  NASDAQ  |  Oct 19, 16:00
1.585 0.00 (0.00%) After-Hours: 16:14
More

Autolus Therapeutics Cash from Operations (Annual) : -284.23M for Dec. 31, 2025

Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 -284.23M
December 31, 2024 -206.36M
December 31, 2023 -145.59M
December 31, 2022 -112.24M
December 31, 2021 -117.86M
Date Value
December 31, 2020 -117.76M
December 31, 2019 -101.48M
September 30, 2018 -31.54M
September 30, 2017 -16.36M
September 30, 2016 -9.849M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Bicycle Therapeutics Plc -250.26M
Biodexa Pharmaceuticals Plc -7.268M
argenx SE 850.49M
Mereo BioPharma Group Plc -31.04M
Evaxion AS -6.645M